Advertisement
Advertisement

PRFX

PRFX logo

PainReform Ltd

4.46
USD
-0.84
-15.85%
Dec 23, 15:59 UTC -5
Closed
...

PainReform Ltd Profile

About

PainReform Ltd.is a clinical stage specialty pharmaceutical company. It engages in the development of products for the treatment of pain. The company's product pipeline includes PRF-110, a product based on local anesthetic ropivacaine, which is in clinical stage. PainReform Ltd.is based in Herzeliya, Israel.

Info & Links

CEO

Ilan Hadar

Headquarters

65 YIGAL ALON ST.
TEL AVIV, L3 6744316, ISRAEL

Industry

Pharmaceuticals Major

Sector

Health Technology

Website

www.painreform.com

Auditor

Kesselman & Kesselman

Share holders

3

Employees

7

PainReform Ltd Statistics

Valuation Measures

Market Capitalization2

624.40K

Enterprise Value

-2.17M

Enterprise Value/EBITDA(ttm)

0.39

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-450.64%

Return on Invested Capital(ttm)

-297.94%

Return on Assets(ttm)

-241.33%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

--

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-5.56M

Net Income Available to Common(ttm)

-5.51M

Diluted EPS(ttm)

-147.33

Share Statistics

Beta (5Y Monthly)

0.74

52-Week Change

-93.19%

S&P 500 52-Week Change

25.12%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

95.00K

% Held by Insiders

34.40%

% Held by Institutions

37.28%

Balance Sheet

Total Cash(mrq)

2.79M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

--

Quick Ratio(mrq)

1.61%

Book Value Per Share(mrq)

--

Cash Flow

Operating Cash Flow Per Share(ytd)

--

Free Cash Flow(ytd)

0.00

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement